Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...

The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

Wegovy (semaglutide) is a prescription drug used for weight loss and to lower risk of cardiovascular problems. The drug comes as a liquid solution for injection under your skin. It’s usually ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

PLAINSBORO, N.J., March 24, 2025 /PRNewswire/ -- Today, Novo Nordisk announced updates to the Wegovy® savings program, allowing all eligible cash-paying patients access to Wegovy® (semaglutide ...

The list price of Wegovy – nearly $1,350 per month ... in duration than the mid-stage studies and likely involve slower titration. That refers to how quickly patients start at a lower ...